CodeMap® Compliance Briefing: August 22, 2018
Editor's Welcome: Almost all laboratory professionals know by now that the Protecting Access to Medicare Act of 2014 significantly reduced Medicare reimbursement for a majority of tests and procedures listed on the Medicare Clinical Laboratory Fee Schedule (CLFS). PAMA also requires the Office of Inspector General (OIG) to periodically conduct analysis and make reports concerning how well the federal government, through the Centers for Medicare and Medicaid Services (CMS), has implemented PAMA and the resultant payment system. Last month, the OIG issued its second report concerning CMS' implementation of PAMA. The report details CMS' implementation of PAMA, describes the new payment rates included in the CLFS since January 2018, and identifies several interesting challenges and risks experienced by CMS during the implementati....
Sorry, access to this content requires a current subscription.
Click here for publications catalog.
CPT copyright 2021 American Medical Association. All rights reserved.
* The responsibility for the content of any "National Correct Coding Policy" included in this product is with the Centers for Medicare and Medicaid
Services and no endorsement by the AMA is intended or should be implied. The AMA disclaims responsibility for any consequences or liability attributable to or related
to any use, nonuse, or interpretation of information contained in this product.